<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oxygen Concentrator Inc News &#187; Seniors/Aging</title>
	<atom:link href="http://oxygenconcentratorinc.com/oxygennews/category/seniorsaging/feed/" rel="self" type="application/rss+xml" />
	<link>http://oxygenconcentratorinc.com/oxygennews</link>
	<description></description>
	<lastBuildDate>Sun, 18 Dec 2011 17:19:34 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Anti-Aging Pathway Enhances Cell Stress Response</title>
		<link>http://oxygenconcentratorinc.com/oxygennews/anti-aging-pathway-enhances-cell-stress-response/</link>
		<comments>http://oxygenconcentratorinc.com/oxygennews/anti-aging-pathway-enhances-cell-stress-response/#comments</comments>
		<pubDate>Fri, 20 Feb 2009 22:25:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Seniors/Aging]]></category>
		<category><![CDATA[Hyperbaric Medicine]]></category>
		<category><![CDATA[oxygen concentrator]]></category>
		<category><![CDATA[oxygen concentrators]]></category>
		<category><![CDATA[portable concentrator]]></category>
		<category><![CDATA[sequal technologies inc]]></category>

		<guid isPermaLink="false">http://oxygenconcentratorinc.com/oxygennews/?p=153</guid>
		<description><![CDATA[People everywhere are feeling the stress of a worldwide recession. Our cells, too, are under continual assault from stress.
Hidden from sight, our cells battle challenges such as their environment, bacteria, viruses, too much or too little oxygen, and physiological stressors. Molecular systems protect cells under assault, but those systems can break down, especially with age.

To [...]]]></description>
			<content:encoded><![CDATA[<p>People everywhere are feeling the stress of a worldwide recession. Our cells, too, are under continual assault from stress.</p>
<p>Hidden from sight, our cells battle challenges such as their environment, bacteria, viruses, too much or too little oxygen, and physiological stressors. Molecular systems protect cells under assault, but those systems can break down, especially with age.<br />
<span id="more-153"></span><br />
To better understand how cells are protected from stress and damage, a team led by Northwestern University researchers studied the effect of resveratrol, a beneficial chemical found in red wine, on human cells in tissue culture.</p>
<p>The findings may help explain what happens in neurodegenerative diseases, which are age-related, when cell protection fails, proteins misfold, lots of damage accumulates and the system falls apart.</p>
<p>The researchers discovered a new molecular relationship critical to keeping cells healthy across a long span of time: a protein called SIRT1, important for caloric restriction and lifespan and activated by resveratrol, regulates heat shock factor 1 (HSF1), keeping it active. HSF1 in turn senses the presence of damaged proteins in the cell and elevates the expression of molecular chaperones to keep a cell&#8217;s proteins in a folded, functional state. Regulation of this pathway has a direct beneficial effect to cells, the research shows.</p>
<p>This role of SIRT1 &#8212; a protein already of great interest to pharmaceutical companies &#8212; was not previously known. The results will be published in the Feb. 20 issue of the journal Science.</p>
<p>&#8220;When SIRT1 levels are high, you are in a high-protection mode,&#8221; said Richard I. Morimoto, Bill and Gayle Cook Professor of Biochemistry, Molecular Biology and Cell Biology in Northwestern&#8217;s Weinberg College of Arts and Sciences. He led the research team.</p>
<p>&#8220;Ironically, triggering the stress response and perhaps maintaining the cell in a protective state over a long period of time can keep cells healthy,&#8221; said Morimoto. &#8220;The cell is protected against an accumulation of damage when HSF1 is more active.&#8221;</p>
<p>SIRT1 levels decrease as humans age, Morimoto explains. Cells can&#8217;t respond to stress as well. This decrease in SIRT1 may help explain why protein misfolding diseases, such as Alzheimer&#8217;s, Parkinson&#8217;s, Huntington&#8217;s and adult-onset diabetes, are diseases of aging.</p>
<p>&#8220;We now have a powerful way to think about addressing neurodegenerative diseases,&#8221; said Morimoto. &#8220;We have identified a pathway that can be manipulated to alter lifespan. Discovering this new basis for therapeutics is very exciting.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://oxygenconcentratorinc.com/oxygennews/anti-aging-pathway-enhances-cell-stress-response/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arthritis And Total Knee Replacements: New Study Still Finds Racial Disparity in Treatment</title>
		<link>http://oxygenconcentratorinc.com/oxygennews/arthritis-and-total-knee-replacements-new-study-still-finds-racial-disparity-in-treatment/</link>
		<comments>http://oxygenconcentratorinc.com/oxygennews/arthritis-and-total-knee-replacements-new-study-still-finds-racial-disparity-in-treatment/#comments</comments>
		<pubDate>Fri, 20 Feb 2009 22:23:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Seniors/Aging]]></category>
		<category><![CDATA[centers for disease control]]></category>
		<category><![CDATA[healthcare providers]]></category>
		<category><![CDATA[medicare claims data]]></category>
		<category><![CDATA[mortality weekly report]]></category>
		<category><![CDATA[osteoarthritis]]></category>

		<guid isPermaLink="false">http://oxygenconcentratorinc.com/oxygennews/?p=151</guid>
		<description><![CDATA[A new study just released found blacks remain less likely than whites to undergo total knee replacement, an important intervention for reducing pain and improving physical function among those with disabling knee osteoarthritis. The study also found total knee replacements are increasing substantially in both populations. According to the Arthritis Foundation, the research underscores the [...]]]></description>
			<content:encoded><![CDATA[<p>A new study just released found blacks remain less likely than whites to undergo total knee replacement, an important intervention for reducing pain and improving physical function among those with disabling knee osteoarthritis. The study also found total knee replacements are increasing substantially in both populations. According to the Arthritis Foundation, the research underscores the need for healthcare providers and people of all races to take proactive measures in preventing and managing the disease.<br />
<span id="more-151"></span><br />
The Morbidity and Mortality Weekly Report study released by the Centers for Disease Control and Prevention, used Medicare claims data from 2000 to 2006 to estimate the national and state-specific total knee replacements for blacks and whites among U.S. adults aged 65 and older.</p>
<p>The study found that among Medicare enrollees, the prevalence of total knee replacements increased by 58 percent overall. Despite the substantial increase in the rates of total knee replacements for both populations, total knee replacements among blacks was 37 percent lower than for whites in 2000, and remained virtually unchanged in 2006. In addition, the rates for total knee replacements were lowest among black men and highest among white women.</p>
<p>The Importance of Taking Action</p>
<p>According to the Arthritis Foundation, most Americans are unaware of the seriousness of arthritis and the impact it can have on their lives. Arthritis is the nation&#8217;s most common cause of disability and costs the U.S. economy more than $128 billion annually. Knee osteoarthritis, the most frequent form of lower extremity arthritis, contributes to 418,000 knee replacement procedures annually and in 2006 accounted for 496,000 hospital discharges and $19 billion in hospital costs.</p>
<p>&#8220;Nearly one in two adults may develop knee osteoarthritis over their lifetime, with an equal risk among blacks and whites,&#8221; said Patience White, MD, MA, chief public health officer for the Arthritis Foundation. &#8220;There are steps Americans can take now to prevent increasing disability from knee osteoarthritis and, if surgery becomes necessary, to better prepare themselves.&#8221;</p>
<p>Tips for Reducing Knee Pain</p>
<p>To reduce the pain and disability of arthritis, the Arthritis Foundation recommends the following:</p>
<p>    * Understand the myth about physical activity and arthritis. Many people think that physical activity can worsen arthritis pain. Nothing could be farther from the truth. Done appropriately, physical activity can help decrease symptoms of knee osteoarthritis. In addition, physical activity is an important component of weight control and helps maintain healthy bones, muscles and joints. For joint-safe exercise programs, try the Arthritis Foundation&#8217;s Life Improvement Series land or water exercise programs offered at more than 1,700 locations nationwide.</p>
<p>    * Control weight. For those already living with symptoms, losing 15 pounds can cut knee pain in half. Maintaining a healthy weight also can lower a person&#8217;s risk of osteoarthritis. In fact, one study showed that women who lost as little as 11 pounds halved their risk of developing knee osteoarthritis and its accompanying joint pain.1</p>
<p>    * Discover techniques to manage your arthritis. Participate in the Arthritis Foundation Self-Help Program, a self-management course that teaches people with arthritis how to manage the pain and challenges that arthritis imposes. The course has been shown to lead to a 40 percent reduction in pain.</p>
<p>    * Learn more. Contact your local local Arthritis Foundation office or visit www.arthritis.org to learn about programs offered in your area and to order free educational materials, including literature on arthritis in African Americans. For more actions you can take, visit take control of osteoarthritis (http://www.arthritis.org/prevent-osteoarthritis.php) to get started. </p>
<p>About the Arthritis Foundation</p>
<p>The Arthritis Foundation is the leading health organization addressing the needs of some 46 million Americans living with arthritis, the nation&#8217;s most common cause of disability. Founded in 1948, with headquarters in Atlanta, the Arthritis Foundation has multiple service points located throughout the country.</p>
<p>The Arthritis Foundation is the largest private, not-for-profit contributor to arthritis research in the world, funding more than $400 million in research grants since 1948. The foundation helps individuals take control of arthritis by providing public health education; pursuing public policy and legislation; and conducting evidence-based programs to improve the quality of life for those living with arthritis.</p>
]]></content:encoded>
			<wfw:commentRss>http://oxygenconcentratorinc.com/oxygennews/arthritis-and-total-knee-replacements-new-study-still-finds-racial-disparity-in-treatment/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Alzheimer&#8217;s Disease: Discovery Of Brain Protein May Be Clue To Treatment</title>
		<link>http://oxygenconcentratorinc.com/oxygennews/alzheimers-disease-discovery-of-brain-protein-may-be-clue-to-treatment/</link>
		<comments>http://oxygenconcentratorinc.com/oxygennews/alzheimers-disease-discovery-of-brain-protein-may-be-clue-to-treatment/#comments</comments>
		<pubDate>Fri, 20 Feb 2009 22:22:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Seniors/Aging]]></category>
		<category><![CDATA[amyloid precursor protein]]></category>
		<category><![CDATA[brain cell damage]]></category>
		<category><![CDATA[cell death and differentiation]]></category>
		<category><![CDATA[nerve cells]]></category>

		<guid isPermaLink="false">http://oxygenconcentratorinc.com/oxygennews/?p=149</guid>
		<description><![CDATA[A study from the Buck Institute for Age Research offers a revolutionary new model for Alzheimer&#8217;s disease (AD), a devastating neurodegenerative disorder which afflicts 24 million people worldwide. In an effort to unravel the normal function of a protein implicated in AD, scientists in California and France have discovered a naturally occurring protein that provides [...]]]></description>
			<content:encoded><![CDATA[<p>A study from the Buck Institute for Age Research offers a revolutionary new model for Alzheimer&#8217;s disease (AD), a devastating neurodegenerative disorder which afflicts 24 million people worldwide. In an effort to unravel the normal function of a protein implicated in AD, scientists in California and France have discovered a naturally occurring protein that provides a new therapeutic target for the disease. The finding upsets the current theory that AD is a disease of toxicity stemming from damage caused by sticky plaques that collect in the brain &#8211; this research points to the condition as a disorder involving an imbalance in signaling between neurons. The study appears online in the Nature publication Cell Death and Differentiation.<br />
<span id="more-149"></span><br />
One of the mysteries of AD has been the normal function of the amyloid precursor protein (APP) which are concentrated at the points where neurons connect. Even though the sticky amyloid plaques which have been viewed as a hallmark sign of AD result from APP, it seems unlikely that APP exists simply to cause Alzheimer&#8217;s disease. In their study, scientists from the Buck Institute and the CNRS (Centre Nationale de la Recherche Scientifique) show that APP binds to netrin-1, a protein that helps to guide nerves and their connections in the brain, as well as helping nerve cells to survive. When netrin-1 was given to mice that have a gene for Alzheimer&#8217;s disease their symptoms were reversed, and the sticky amyloid was reduced. These results suggest that the long-held belief that AD is caused by brain cell damage inflicted by the amyloid plaques may be wrong; instead, it is beginning to appear that the disease stems from an imbalance between the normal making and breaking of connections in the brain, with netrin-1 supporting the connections and the amyloid breaking the connections &#8212; both by binding to APP and activating normal cell programs. Not only did the netrin-1 binding to APP keep the nerve cells alive and connected, but it also shut down the production of the amyloid, all of which makes it an interesting potential therapeutic.</p>
<p>&#8220;I think we&#8217;re going to see an explosion in the next five years involving the dissection of these signaling pathways whose imbalance leads to Alzheimer&#8217;s disease,&#8221; said Buck Institute Faculty Member Dale Bredesen, MD, who led the California half of the French-Californian collaborative research. &#8220;We now believe that APP is part of a &#8216;plasticity module&#8217; that functions in normal memory and forgetting, and that netrin-1 gives us an important starting point to restore the normal balance.&#8221;</p>
<p>&#8220;We believe that Alzheimer&#8217;s disease is somewhat analogous to cancer, which results from an imbalance between the normal processes that support cell survival and those that cause cell turnover,&#8221; said Patrick Mehlen, PhD, Director of the Apoptosis, Cancer and Development CNRS Laboratory at the University of Lyon and co-senior author of the study. &#8220;Our hope is that this research will lead to therapeutics that will be used to address this imbalance much earlier in the disease process.&#8221;</p>
<p>Research is underway to develop a drug based on the findings. The Buck Institute and the CNRS in Lyon are partnering with Neurobiological Technologies Inc., (NASDAQ: NTII) to bring the discovery from the laboratory to clinical trials. </p>
]]></content:encoded>
			<wfw:commentRss>http://oxygenconcentratorinc.com/oxygennews/alzheimers-disease-discovery-of-brain-protein-may-be-clue-to-treatment/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

